FASLG and skin basal cell carcinoma: In a study of 15 patients with histologically proven nodular BCC, 9 of whom were treated with intralesional IFN-α-2b, the BCC cells of untreated patients constitutively expressed CD95L, whereas the BCC cells of treated patients not only expressed CD95L but also became CD95 positive.